Article
CDKN1C (p57(Kip2)) analysis in Beckwith-Wiedemann syndrome (BWS) patients: Genotype-phenotype correlations, novel mutations, and polymorphisms.
American journal of medical genetics. Part A - 1 Jun 2010
Romanelli Valeria, Belinchón Alberta, Benito-Sanz Sara, Martínez-Glez Victor, Gracia-Bouthelier Ricardo, Heath Karen E, Campos-Barros Angel, García-Miñaur Sixto, Fernandez Luís, Meneses Heloisa, López-Siguero Juan Pedro, Guillén-Navarro Encarna, Gómez-Puertas Paulino, Wesselink Jan-Jaap, Mercado Graciela, Esteban-Marfil Victoria, Palomo Rebeca, Mena Rocío, Sánchez Aurora, Del Campo Miguel, Lapunzina Pablo
Abstract excerpt
Beckwith-Wiedemann syndrome (BWS) is an overgrowth syndrome characterized by macroglossia, macrosomia, and abdominal wall defects. It is a multigenic disorder caused in most patients by alterations in growth regulatory genes. A small number of individuals with BWS (5-10%) have mutations in CDKN1C, a cyclin-dependent kinase inhibitor of G1 cyclin complexes that functions as a negative regulator of cellular growth...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
